Otezla Oral Tablet 10-20-30Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Otezla: Oral tablet (10-20-30mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

APREMILAST (a PRE mil ast) is used to treat plaque psoriasis and psoriatic arthritis.

In-Depth Information
Select a Medication

Otezla Tablet Starter Pack

NDC: 595720630
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Psoriasis, Psoriatic Arthritis

Storage Information
Store below 86 degrees F
Otezla Tablet Starter Pack

Reported Side Effects for Otezla Tablet Starter Pack

Weight Loss Incidence:
<12.0%*
Severity: MILD
Onset: DELAYED
Thoughts Of Suicide Incidence:
0.1-0.2%*
Severity: SEVERE
Onset: DELAYED
Sore Throat Incidence:
0.2-2.6%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
0.6-4.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
0.6-9.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
0.8-4.0%*
Severity: MILD
Onset: EARLY
Inflamed Hair Follicles Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
1.0-1.3%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Migraine Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
4.8-5.9%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
7.4-17.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
7.7-17.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Otezla

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.